Zyla Life Sciences Net Change in Cash
Zyla Life Sciences reported Net Change in Cash of $2.58 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2020-05-14
- Zyla Life Sciences cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $2.58M.
- Zyla Life Sciences cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-03-31 was $2.59M.
- Zyla Life Sciences cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2017-03-31 was -$17.37M.
- Zyla Life Sciences cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was $4.23M.
- Zyla Life Sciences cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2017 was -$12.87M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $2.58M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | -$5.08M 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | $1.55M 10-Q · filed 2019-11-14 | ||||||||
| 2019-06-30 | -$4.99M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | -$6.66M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | -$18.28M 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | $4.23M 10-K · filed 2020-03-26 | ||||||||
| 2018-09-30 | $3.16M 10-Q · filed 2019-11-14 | ||||||||
| 2018-06-30 | $6.74M 10-Q · filed 2018-08-09 | ||||||||
| 2018-03-31 | $2.59M 10-Q · filed 2018-05-10 | ||||||||
| 2017-12-31 | -$12.87M 10-K · filed 2019-03-29 | ||||||||
| 2017-09-30 | -$6.21M 10-Q · filed 2018-11-19 | ||||||||
| 2017-06-30 | -$14.09M 10-Q · filed 2018-08-09 | ||||||||
| 2017-03-31 | -$17.37M 10-Q · filed 2018-05-10 |